These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17314684)

  • 41. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atrasentan treatment of pulmonary vascular disease in piglets with increased pulmonary blood flow.
    Gorenflo M; Ullmann MV; Herpel E; Neumayer S; Dieckmann R; Demirakca S; Klimpel H; Hagl S; Gebhard MM
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):286-92. PubMed ID: 17878757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement in lung diffusion by endothelin A receptor blockade at high altitude.
    de Bisschop C; Martinot JB; Leurquin-Sterk G; Faoro V; Guénard H; Naeije R
    J Appl Physiol (1985); 2012 Jan; 112(1):20-5. PubMed ID: 21979801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008].
    Cacoub P; Amoura Z; Langleben D
    Rev Med Interne; 2008 Apr; 29(4):283-9. PubMed ID: 18243424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients.
    Soldano S; Montagna P; Brizzolara R; Ferrone C; Parodio A; Sulli A; Seriolo B; Villaggio B; Cutolo M
    Reumatismo; 2012 Dec; 64(5):326-34. PubMed ID: 23256109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases.
    Humbert M; Simonneau G
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):93-101. PubMed ID: 16932638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of the serotonin 1b receptor in experimental pulmonary hypertension.
    Rondelet B; Van Beneden R; Kerbaul F; Motte S; Fesler P; McEntee K; Brimioulle S; Ketelslegers JM; Naeije R
    Eur Respir J; 2003 Sep; 22(3):408-12. PubMed ID: 14516127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of long-term bosentan in children with pulmonary arterial hypertension.
    Rosenzweig EB; Ivy DD; Widlitz A; Doran A; Claussen LR; Yung D; Abman SH; Morganti A; Nguyen N; Barst RJ
    J Am Coll Cardiol; 2005 Aug; 46(4):697-704. PubMed ID: 16098438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
    Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M
    J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of sitaxsentan treatment on quality of life in pulmonary arterial hypertension.
    Souza R; Martins BC; Jardim C; Cortopassi F; Fernandes CJ; Pulido T; Sandoval J
    Int J Clin Pract; 2007 Jan; 61(1):153-6. PubMed ID: 17229188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelin receptor blockers in cardiovascular disease.
    Rich S; McLaughlin VV
    Circulation; 2003 Nov; 108(18):2184-90. PubMed ID: 14597580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transfection of human hepatocyte growth factor gene inhibits advancing pulmonary arterial hypertension induced by shunt flow in a rabbit model.
    Liu R; Wu S; Cao G; Wang W; Liu K; Wu S
    Transplant Proc; 2013 Mar; 45(2):705-12. PubMed ID: 23498810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets.
    Perreault T; Berkenbosch JW; Barrington KJ; Decker ER; Wu C; Brock TA; Baribeau J
    Pediatr Res; 2001 Sep; 50(3):374-83. PubMed ID: 11518825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow.
    Black SM; Mata-Greenwood E; Dettman RW; Ovadia B; Fitzgerald RK; Reinhartz O; Thelitz S; Steinhorn RH; Gerrets R; Hendricks-Munoz K; Ross GA; Bekker JM; Johengen MJ; Fineman JR
    Circulation; 2003 Sep; 108(13):1646-54. PubMed ID: 12963646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Right lung ischemia induces contralateral pulmonary vasculopathy in an animal model.
    Sage E; Mercier O; Herve P; Tu L; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):967-73. PubMed ID: 22284626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus.
    Ivy DD; Parker TA; Ziegler JW; Galan HL; Kinsella JP; Tuder RM; Abman SH
    J Clin Invest; 1997 Mar; 99(6):1179-86. PubMed ID: 9077525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
    Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
    Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.